2 - 4 Feb 2017
The 2017 EMBL-Cancer Core Europe Conference on Cancer Immunotherapy will cover highly relevant sub-disciplines of cancer immunology with a special focus on personalised immunotherapy.
The European Molecular Biology Laboratory (EMBL) and Cancer Core Europe - a consortium of Europe's 6 leading Comprehensive Cancer Centers (Gustave Roussy Cancer Campus Grand Paris, France; Cambridge Cancer Centre, United Kingdom; Karolinska Institutet, Sweden; Netherlands Cancer Institute (NKI), Vall d’Hebron Institute of Oncology, Spain and the German Cancer Research Centre (DKFZ) with it's National Center for Tumour Diseases (NCT) Heidelberg) - are proud to join forces to host the first EMBL-Cancer Core Europe Conference on Cancer Immunotherapy.
- Unleashing endogenous immunity
- Clinical studies of T cell-based immunotherapies
- Markers of effective immune responses
- Targeting the microenvironment
- Inducing immunity
For more information please visit: http://www.embl.de/training/events/2017/CCE17-01/index.html